The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas
Open accessAbstract
OBJECTIVE: We estimate the effect size of hypoglycemia risk reduction on closed-loop control (CLC) versus open-loop (OL) sensor-augmented insulin pump therapy in supervised outpatient setting. RESEARCH DESIGN AND METHODS: Twenty patients with type 1 diabetes initiated the study at the Universities of Virginia, Padova, and Montpellier and Sansum Diabetes Research Institute; 18 completed the entire protocol. Each patient participated in two 40-h outpatient sessions, CLC versus OL, in randomized order. Sensor (Dexcom G4) and insulin pump (Tandem t:slim) were connected to Diabetes Assistant (DiAs)—a smartphone artificial pancreas platform. The patient operated the system through the DiAs user interface during both CLC and OL; study personnel supervised on site and monitored DiAs remotely. There were no dietary restrictions; 45-min walks in town and restaurant dinners were included in both CLC and OL; alcohol was permitted. RESULTS: The primary outcome—reduction in risk for hypoglycemia as measured by the low blood glucose (BG) index (LGBI)—resulted in an effect size of 0.64, P = 0.003, with a twofold reduction of hypoglycemia requiring carbohydrate treatment: 1.2 vs. 2.4 episodes/session on CLC versus OL (P = 0.02). This was accompanied by a slight decrease in percentage of time in the target range of 3.9–10 mmol/L (66.1 vs. 70.7%) and increase in mean BG (8.9 vs. 8.4 mmol/L; P = 0.04) on CLC versus OL. CONCLUSIONS: CLC running on a smartphone (DiAs) in outpatient conditions reduced hypoglycemia and hypoglycemia treatments when compared with sensor-augmented pump therapy. This was accompanied by marginal increase in average glycemia resulting from a possible overemphasis on hypoglycemia safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hovorka, R., Kumareswaran, K., Harris, J., Allen, J. M., Elleri, D., Xing, D., Kollman, C., Nodale, M., Murphy, H. R., Dunger, D. B., et al. (2011) · BMJ · doi:10.1136/bmj.d1855 · Cited by 244
Clarke, W. L., Anderson, S., Breton, M., Patek, S., Kashmer, L., & Kovatchev, B. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300506 · Cited by 185
Self-citation
Research works printed but not linked: 20
- Cobelli, 2011, Artificial pancreas: past, present, future, Diabetes, 60, 2672, 10.2337/db11-0654 · DOI · Paper page
- Weinzimer, 2008, Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas, Diabetes Care, 31, 934, 10.2337/dc07-1967 · DOI · Paper page
- Bruttomesso, 2009, Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier, J Diabetes Sci Tech, 3, 1014, 10.1177/193229680900300504 · DOI
- Hovorka, 2010, Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial, Lancet, 375, 743, 10.1016/S0140-6736(09)61998-X · DOI · Paper page
- El-Khatib, 2010, A bihormonal closed-loop artificial pancreas for type 1 diabetes, Sci Transl Med, 2, 27ra27, 10.1126/scitranslmed.3000619 · DOI · Paper page
- Atlas, 2010, MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes, Diabetes Care, 33, 1072, 10.2337/dc09-1830 · DOI · Paper page
- Renard, 2010, Closed-loop insulin delivery using subcutaneous infusion and glucose sensing, and equipped with a dedicated safety supervision algorithm, improves safety of glucose control in type 1 diabetes, Diabetologia, 53, S25
- Dassau, 2013, Diabetes Care, 36, 801, 10.2337/dc12-0948 · DOI
- Phillip, 2013, Nocturnal glucose control with an artificial pancreas at a diabetes camp, N Engl J Med, 368, 824, 10.1056/NEJMoa1206881 · DOI · Paper page
- Nimri, 2013, Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis, Pediatr Diabetes
- Keith-Hynes, 2013, DiAs user interface: a patient-centric interface for mobile artificial pancreas systems, J Diabetes Sci Tech, 7, 1416, 10.1177/193229681300700602 · DOI
- O’Grady, 2012, The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes, Diabetes Care, 35, 2182, 10.2337/dc12-0761 · DOI
- Cobelli, 2012, Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes, Diabetes Care, 35, e65, 10.2337/dc12-0660 · DOI
- Kovatchev, 2013, Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas, Diabetes Care, 36, 1851, 10.2337/dc12-1965 · DOI · Paper page
- Kovatchev, 1998, Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index, Diabetes Care, 21, 1870, 10.2337/diacare.21.11.1870 · DOI · Paper page
- Place, 2013, DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials, J Diabetes Sci Tech, 7, 1427, 10.1177/193229681300700603 · DOI
- Patek, 2012, Modular closed-loop control of diabetes, IEEE Trans Biomed Eng, 59, 2986, 10.1109/TBME.2012.2192930 · DOI · Paper page
- Hughes, 2010, Hypoglycemia prevention via pump attenuation and red-yellow-green “traffic” lights using continuous glucose monitoring and insulin pump data, J Diabetes Sci Technol, 4, 1146, 10.1177/193229681000400513 · DOI
- Ellingsen, 2009, Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board, J Diabetes Sci Technol, 3, 536, 10.1177/193229680900300319 · DOI
- Soru, 2012, Annu Rev Contr, 36, 118, 10.1016/j.arcontrol.2012.03.009 · DOI
Cited by
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
“…et w ee n 1 0 :0 0 p .m . an d 7 :0 0 a. m . a W il co x o n si g n ed -r an k te st . study of long enough duration to obtain HbA1c levels, and by Kovatchev et al.14 who performed a 6-month closed-loop control study in a limited number of individuals with a low baseline HbA1c of 7.2% that was…”
MethodInfluentialSelf-citationWeisman, A., Bai, J.-W., Cardinez, M., Kramer, C. K., & Perkins, B. A. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30167-5 · Cited by 463
Mobile technology and the digitization of healthcare
Bhavnani, S. P., Narula, J., & Sengupta, P. P. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv770 · Cited by 454
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Bekiari, E., Kitsios, K., Thabit, H., Tauschmann, M., Athanasiadou, E., Karagiannis, T., Haidich, A.-B., Hovorka, R., & Tsapas, A. (2018) · BMJ · doi:10.1136/bmj.k1310 · Cited by 437
In silico clinical trials: how computer simulation will transform the biomedical industry
Viceconti, M., Henney, A., & Morley-Fletcher, E. (2016) · International Journal of Clinical Trials · doi:10.18203/2349-3259.ijct20161408 · Cited by 289
El-Khatib, F. H., Balliro, C., Hillard, M. A., Magyar, K. L., Ekhlaspour, L., Sinha, M., Mondesir, D., Esmaeili, A., Hartigan, C., Thompson, M. J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32567-3 · Cited by 254
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234
Self-citationComing of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223
ISPAD Clinical Practice Consensus Guidelines 2018: diabetes technologies
Sherr, J. L., Tauschmann, M., Battelino, T., de Bock, M., Forlenza, G., Roman, R., Hood, K. K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12731 · Cited by 197
Breton, M. D., Cherñavvsky, D. R., Forlenza, G. P., DeBoer, M. D., Robic, J., Wadwa, R. P., Messer, L. H., Kovatchev, B. P., & Maahs, D. M. (2017) · Diabetes Care · doi:10.2337/dc17-0883 · Cited by 179
“inpatient investigations using algorithmdriven manual control (5) to long-term clinical trials in free-living conditionsusing portable wireless automated CLC systems (6).”
MethodSelf-citationLeveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Multinational Home Use of Closed-Loop Control Is Safe and Effective
Anderson, S. M., Raghinaru, D., Pinsker, J. E., Boscari, F., Renard, E., Buckingham, B. A., Nimri, R., Doyle, F. J., Brown, S. A., Keith-Hynes, P., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2468 · Cited by 120
Self-citationGingras, V., Taleb, N., Roy‐Fleming, A., Legault, L., & Rabasa‐Lhoret, R. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13052 · Cited by 113
Renard, E., Farret, A., Kropff, J., Bruttomesso, D., Messori, M., Place, J., Visentin, R., Calore, R., Toffanin, C., Di Palma, F., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0008 · Cited by 104
Self-citationCare of diabetes in children and adolescents: controversies, changes, and consensus
Cameron, F. J., & Wherrett, D. K. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60971-0 · Cited by 99
The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes
Kovatchev, B., Tamborlane, W. V., Cefalu, W. T., & Cobelli, C. (2016) · Diabetes Care · doi:10.2337/dc16-0824 · Cited by 95
Self-citationGarcia-Tirado, J., Diaz, J. L., Esquivel-Zuniga, R., Koravi, C. L. K., Corbett, J. P., Dawson, M., Wakeman, C., Barnett, C. L., Oliveri, M. C., Myers, H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0932 · Cited by 52
Self-citationDeveloping the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility
Cobelli, C., & Kovatchev, B. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231195081 · Cited by 46
Self-citationFang, Z., Liu, M., Tao, J., Li, C., Zou, F., & Zhang, W. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01674-6 · Cited by 38
Effect of Afrezza on Glucose Dynamics During HCL Treatment
Galderisi, A., Cohen, N., Calhoun, P., Kraemer, K., Breton, M., Weinzimer, S., & Cengiz, E. (2020) · Diabetes Care · doi:10.2337/dc20-0091 · Cited by 32
Self-citation
Metadata
- Authors
- Kovatchev, B. P., Renard, E., Cobelli, C., Zisser, H. C., Keith-Hynes, P., Anderson, S. M., Brown, S. A., Chernavvsky, D. R., Breton, M. D., Mize, L. B., Farret, A., Place, J., Bruttomesso, D., Del Favero, S., Boscari, F., Galasso, S., Avogaro, A., Magni, L., Di Palma, F., Toffanin, C., Messori, M., Dassau, E., & Doyle, F. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-06-12
- Volume
- 37
- Issue
- 7
- Pages
- 1789-1796
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2134076472
- Cited by
- 178
- References
- 2
- FWCI
- 23.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.